SynthesisBMC psychiatry2025
Psychotherapeutic, pharmacological and other active interventions from the NICE guideline for post-traumatic stress disorder with sleep disorder: systematic review and meta-analysis.
Synthesis in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- From Biomarkers to New Treatments for Post-Traumatic Stress Disorder.Neuroscience bulletin · 2026Review
- Self-Poisoning With Prazosin and Its Off-Label Use in Australia, 2014-2024: Analysis of NSW Poisons Information Centre Data.The Medical journal of Australia · 2026Article
- Sleep Disturbances Among Yazidi Survivors of the ISIS Genocide: Epidemiology, Neuropsychology, and Culturally Sensitive Interventions.Brain and behavior · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPost-traumatic stress disorder (PTSD) is strongly associated with sleep disorders, and current clinical guidelines for PTSD differ in recommending treatment for patients with PTSD associated with sleep disorders. This meta-analysis evaluates the acceptability and efficacy of psychotherapy, pharmacotherapy, and other complementary/alternative therapies, to help clinicians make decisions about treatment regimens for individuals with PTSD and sleep disorders.
methodWe systematically searched PubMed, EMBASE, the Cochrane Library, and American Psychological Association PsyNet for randomized controlled trials (RCTs) related to placebo-controlled and active intervention trials for PTSD with sleep disorders up to February 2, 2023.
resultsActive intervention significantly improved PTSD (standardized mean difference (SMD) = 0.86, 95% confidence interval (CI): 1.21, 0.50), sleep disorders (SMD = 1.06, 95%CI: 1.50, 0.63), and depression (SMD = 0.58, 95%CI: -0.96, -0.19). Regarding compliance, the active intervention group did not show lower acceptability ((Risk ratios (RR) = 1.08, 95%CI: 0.92, 1.26). Compared to placebo or supportive groups, the active intervention did not exhibit statistically significant improvements in total sleep time (SMD = 0.87, 95%CI: -0.27, 1.47) and overall psychological symptoms (SMD = 0.13, 95%CI: -0.12, 0.37). Details results of the subgroup analyses were provided in the text. Bias may be present in total PTSD symptoms, change of total sleep symptoms and change of depression symptoms, and no significant bias was observed in acceptability.
conclusionActive intervention effectively reduces the main symptoms of PTSD in patients with sleep disorders. Consideration of pharmacotherapy (hydroxyzine) is recommended over prazosin, as suggested by the WFSBP clinical guidelines, especially when patients are insensitive to psychotherapy or have urgent symptoms. Psychological interventions, particularly IRT or IRT plus CBT-I, are recommended. Stratified by population, psychotherapy is more advisable for veterans and those with involuntary sexual experiences, while pharmacotherapy is more suitable for military staff. For patients with only nightmare symptoms, both psychotherapy and pharmacotherapy could be considered. When patients have insomnia symptoms, psychotherapy is preferable. The effect of psychotherapy is particularly recommended for females, while the effect of pharmacotherapy is emphasized for males.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.